CARMAT, the innovative French MedTech company behind the groundbreaking Aeson® artificial heart, has successfully secured €11.5 million in funding to bolster its mission of transforming cardiac care for patients suffering from end-stage biventricular heart failure. Founded in 2008 and headquartered in the Paris region, CARMAT has developed the world's first physiological artificial heart, designed to be highly hemocompatible, pulsatile, and self-regulated. With the growing demand for heart transplants outpacing the availability of human grafts, Aeson® offers a vital therapeutic alternative, aiming to save thousands of lives annually. The newly acquired funds will be instrumental in furthering CARMAT's research and development efforts, enabling the company to enhance the Aeson® device and expand its market presence. Currently available as a bridge to transplant in the European Union and other CE-mark-recognizing countries, Aeson® is also undergoing evaluation in the United States through an Early Feasibility Study (EFS). This additional financing will not only support ongoing clinical studies but will also facilitate production scalability and the enhancement of the product’s user-friendly external power supply system, allowing patients improved mobility and quality of life. CARMAT prides itself on its expert team of over 200 professionals dedicated to pioneering life-saving technologies, and this funding underscores the healthcare community's growing confidence in their vision. As the company navigates its next steps, the CARMAT team is excited to move closer to making Aeson® the go-to alternative for heart transplant patients worldwide.
CARMAT Secures $11.5 Million Funding for Breakthrough Artificial Heart Technology
Recently funded · $11.5MHealthcare
Get the full Carmat company profile
Access contacts, investors, buying signals & more
Other recently funded companies
View all
Laihua Online
Wuhan Laihua Information and Technology is an Internet leading source of information on educational opportunities for students to study in other countries especially in China. Either prospect is planning to come to China or is already in China for education (self-support or scholarship based) he will probably need one of the ranges of services we provide from Education, Translation, Notarization of legal documents to Internships & Jobs or Medical Tourism etc. It is a comprehensive directory of study abroad programs, including summer study abroad, service learning, intensive language programs and more. Wuhan Laihua Information and Technology first set out to fill the information gap between students with a desire to travel abroad to study and companies offering international programs.
$68.0M Series d
today
NEW ID
NEW ID is the latest subsidiary company of NEW, which has started up since August 2019 for a new digital contents/platform business domain. We are responsible for expanding the contents produced and acquired by NEW into various markets and creating our digital capabilities through partnering with a-lister digital content creators and providers in Korea.
